Skip to Content

SEC Filing Details

Document Details

Form
Filing Date
Feb 13, 2024
Document Date
Dec 31, 2023
Form Description
Annual filing director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Cerevel Therapeutics
Issuer
CEREVEL THERAPEUTICS HOLDINGS, INC.
Filer
SULZBERGER GABRIELLE

Cerevel is now part of AbbVie

Together we will deliver science that takes us closer to meaningful change for people with neurological and psychiatric disorders.

Read the press release